SlideShare a Scribd company logo
1 of 10
HYPOTHYROIDISM
     AND BODY WEIGHT:
    LONG-TERM CHANGES
DURING REPLACEMENT THERAPY

            H. Candiloros
            E. Georgiadou
  Authors
            E. Kapantais
            A. Mortoglou
Department of
 Endocrinology, Diabetes & Metabolism


Athens Medical Centre Hospital,
        Athens,   Greece

8th International congress on Obesity
Paris, 29 August - 3 September 1998
Introduction
   There is a general thought that
    hypothyroidism is a cause for
    obesity and that replacement
    therapy leads to a normalisation of
    body weight.
   The aim is to study body weight in
    patients with primary
    hypothyroidism of autoimmune
    aetiology before and after
    replacement therapy .
Subjects


   129 females and 16 males
   Age: 50.5±15.1 years (mean±SD)
   Initial TSH level >10 mU/ml.
Results (Before replacement therapy)
•    Body Weight= 73.9±14.7 kgr
•           BMI= 29.3± 5.7 kgr/m2
TSH= 47.6±32.3 mU/ml,T4= 4.06±2.44 μg/dl, T3= 85.8±39.4 ng/dl.
                        37.9%
               31.7%
                                              There was no correlation
      26.2%                                   between BMI and thyroid
                                              hormones.
                                               T4: r= -0.060, p= 0.470
                                               T3: r= 0.019, p= 0.822
                                 4.2%
                                               TSH: r= 0.059, p= 0.477

      < 25    25-30    30-40    > 40    BMI
73.8% are overweight or obese
Results (6 months after replacement therapy)
         Dose 125.7±28 μg L-Thyroxine

                 BW= 71.3±13.1
                 BMI= 28.5±4.7

  T4= 10.3±2.8, T3= 137.7±34.2, TSH= 1.6±2.8


   Body Weight decreased by 1.55±4.0 kg (p=0.001)
                        and
            BMI by 0.626±1.629 (p=0.001)
Results (18 months after replacement therapy)
         Dose 125.4±29 μg L-Thyroxine

                 BW= 71.2±13.8
                 BMI= 28.4± 5.4

   T4= 10.2±2.3, T3= 128±27.2, TSH= 0.8±1.1


  Body Weight decreased by 0.57± 5.1 kgr (p= 0.408)
                        and
           BMI by 0.262 ± 2.035 (p= 0.344)
Multiple regression analysis
           Body weight changes after 6 months
DEP VAR:change of BW     N:86 MULTIPLE R:0.636 SQUARED MULTIPLE R:0.405
ADJUSTED SQUARED MULTIPLE R: 0.367             STANDARD ERROR OF ESTIMATE: 3.251


 VARIABLE   COEFFICIENT        STD ERROR         STD COEF TOLERANCE              T   P(2 TAIL)
CONSTANT        -6.450      2.863       0.000         .    -2.253    0.027
 Weight      0.070       0.027      0.236      0.890       2.576    0.012
  Age       0.084      0.026       0.304      0.874       3.290    0.001
  T4-0      -0.633     0.147       -0.377     0.965 -4.294         0.000
  T4-6      0.475      0.138       0.326      0.826       3.433    0.001
  T3-6      -0.028     0.011       -0.233     0.862 -2.503         0.014
              ANALYSIS OF VARIANCE
 SOURCE SUM-OF-SQUARES             DF MEAN-SQUARE                  F-RATIO   P
REGRESSION       574.698       5    114.940      10.875           0.000
 RESIDUAL      845.552    80       10.569
Multiple regression analysis
         Body weight changes after 18 months

DEP VAR:Change BW    N:55 MULTIPLE R: 0.650            SQUARED MULTIPLE R:0.422
ADJUSTED SQUARED MULTIPLE R: 0.400             STANDARD ERROR OF ESTIMATE:                3.930


VARIABLE    COEFFICIENT       STD ERROR        STD COEF TOLERANCE             T   P(2 TAIL)
CONSTANT        -5.368     2.364       0.000       .    -2.270    0.027
  Age       0.174    0.040        0.472    0.967       4.403    0.000
  T4-0      -0.795   0.230        -0.370     0.967 -3.450       0.001
               ANALYSIS OF VARIANCE
 SOURCE SUM-OF-SQUARES            DF MEAN-SQUARE               F-RATIO    P
REGRESSION       587.605      2    293.803     19.021          0.000
 RESIDUAL      803.223   52       15.447
Conclusions
 Patients with primary hypothyroidism
  are heavier than general population but
  the degree of hypothyroidism is not
  related to Body Weight.
 The mean weight loss after 6 and 18
  months on replacement therapy is
  negligible (ΔBMI=0.26) and only in elderly
  patients with profound hypothyroidism
  and higher initial Body Weight a slight
  improvement of degree of obesity can be
  achieved (ΔBMI= 1.81).

More Related Content

Similar to 1998 8th ico

1995 6th eco 2
1995 6th eco 21995 6th eco 2
1995 6th eco 2iosis1979
 
1994 7th ico
1994 7th ico1994 7th ico
1994 7th icoiosis1979
 
A Randomized, Masked, Controlled Study of Omega-3 Polyunsaturated Fatty Acid ...
A Randomized, Masked, Controlled Study of Omega-3 Polyunsaturated Fatty Acid ...A Randomized, Masked, Controlled Study of Omega-3 Polyunsaturated Fatty Acid ...
A Randomized, Masked, Controlled Study of Omega-3 Polyunsaturated Fatty Acid ...James Nelson
 
第四組Topic最終版
第四組Topic最終版第四組Topic最終版
第四組Topic最終版Kachang Wu
 
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...European School of Oncology
 
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin Resistance
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin ResistanceThe Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin Resistance
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin ResistanceBiomedical Statistical Consulting
 
1997 alcohol 8th eco
1997 alcohol 8th eco1997 alcohol 8th eco
1997 alcohol 8th ecoiosis1979
 
Hypertrophic obesity is associated with type 2 diabetes and impaired adipogen...
Hypertrophic obesity is associated with type 2 diabetes and impaired adipogen...Hypertrophic obesity is associated with type 2 diabetes and impaired adipogen...
Hypertrophic obesity is associated with type 2 diabetes and impaired adipogen...My Healthy Waist
 
analysis of spss output.docx
analysis of spss output.docxanalysis of spss output.docx
analysis of spss output.docxMagsSeeJe
 
Evaluating cardiometabolic risk
Evaluating cardiometabolic riskEvaluating cardiometabolic risk
Evaluating cardiometabolic riskMy Healthy Waist
 
Dr. Erin Harris - Feeding Strategies for Dried Distillers Grain with Solubles...
Dr. Erin Harris - Feeding Strategies for Dried Distillers Grain with Solubles...Dr. Erin Harris - Feeding Strategies for Dried Distillers Grain with Solubles...
Dr. Erin Harris - Feeding Strategies for Dried Distillers Grain with Solubles...John Blue
 
Hepatobiliary tumor board (1)
Hepatobiliary tumor board (1)Hepatobiliary tumor board (1)
Hepatobiliary tumor board (1)madurai
 
Antalya-1-Messinis-Obesity-and-Infertility.pptx
Antalya-1-Messinis-Obesity-and-Infertility.pptxAntalya-1-Messinis-Obesity-and-Infertility.pptx
Antalya-1-Messinis-Obesity-and-Infertility.pptxMsccMohamed
 
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer SurgeryKshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer SurgeryOleg Kshivets
 
Food Frequency Questionnaire-ValidationStudy-Cardiology2022.pptx
Food Frequency Questionnaire-ValidationStudy-Cardiology2022.pptxFood Frequency Questionnaire-ValidationStudy-Cardiology2022.pptx
Food Frequency Questionnaire-ValidationStudy-Cardiology2022.pptxKazuko Yoshizawa
 
EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS ...
EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS ...EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS ...
EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS ...Yogacharya AB Bhavanani
 

Similar to 1998 8th ico (20)

1995 6th eco 2
1995 6th eco 21995 6th eco 2
1995 6th eco 2
 
1994 7th ico
1994 7th ico1994 7th ico
1994 7th ico
 
A Randomized, Masked, Controlled Study of Omega-3 Polyunsaturated Fatty Acid ...
A Randomized, Masked, Controlled Study of Omega-3 Polyunsaturated Fatty Acid ...A Randomized, Masked, Controlled Study of Omega-3 Polyunsaturated Fatty Acid ...
A Randomized, Masked, Controlled Study of Omega-3 Polyunsaturated Fatty Acid ...
 
第四組Topic最終版
第四組Topic最終版第四組Topic最終版
第四組Topic最終版
 
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...
 
Mubasher, M Phil seminar
Mubasher, M Phil seminarMubasher, M Phil seminar
Mubasher, M Phil seminar
 
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin Resistance
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin ResistanceThe Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin Resistance
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin Resistance
 
1997 alcohol 8th eco
1997 alcohol 8th eco1997 alcohol 8th eco
1997 alcohol 8th eco
 
Harvie opac2013
Harvie opac2013Harvie opac2013
Harvie opac2013
 
Hypertrophic obesity is associated with type 2 diabetes and impaired adipogen...
Hypertrophic obesity is associated with type 2 diabetes and impaired adipogen...Hypertrophic obesity is associated with type 2 diabetes and impaired adipogen...
Hypertrophic obesity is associated with type 2 diabetes and impaired adipogen...
 
analysis of spss output.docx
analysis of spss output.docxanalysis of spss output.docx
analysis of spss output.docx
 
Evaluating cardiometabolic risk
Evaluating cardiometabolic riskEvaluating cardiometabolic risk
Evaluating cardiometabolic risk
 
Dr. Erin Harris - Feeding Strategies for Dried Distillers Grain with Solubles...
Dr. Erin Harris - Feeding Strategies for Dried Distillers Grain with Solubles...Dr. Erin Harris - Feeding Strategies for Dried Distillers Grain with Solubles...
Dr. Erin Harris - Feeding Strategies for Dried Distillers Grain with Solubles...
 
Hepatobiliary tumor board (1)
Hepatobiliary tumor board (1)Hepatobiliary tumor board (1)
Hepatobiliary tumor board (1)
 
Antalya-1-Messinis-Obesity-and-Infertility.pptx
Antalya-1-Messinis-Obesity-and-Infertility.pptxAntalya-1-Messinis-Obesity-and-Infertility.pptx
Antalya-1-Messinis-Obesity-and-Infertility.pptx
 
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer SurgeryKshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
 
Food Frequency Questionnaire-ValidationStudy-Cardiology2022.pptx
Food Frequency Questionnaire-ValidationStudy-Cardiology2022.pptxFood Frequency Questionnaire-ValidationStudy-Cardiology2022.pptx
Food Frequency Questionnaire-ValidationStudy-Cardiology2022.pptx
 
EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS ...
EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS ...EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS ...
EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS ...
 
Adverse effects of inhaled corticosteroids
Adverse effects of inhaled corticosteroidsAdverse effects of inhaled corticosteroids
Adverse effects of inhaled corticosteroids
 
Kirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulation
Kirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulationKirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulation
Kirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulation
 

More from iosis1979

2009 11ο Διαβητολογικό
2009 11ο Διαβητολογικό2009 11ο Διαβητολογικό
2009 11ο Διαβητολογικόiosis1979
 
2008 7ο παχυσαρκίας
2008 7ο παχυσαρκίας2008 7ο παχυσαρκίας
2008 7ο παχυσαρκίαςiosis1979
 
2007 15th eco
2007 15th eco2007 15th eco
2007 15th ecoiosis1979
 
2006 14th ico 2
2006 14th ico 22006 14th ico 2
2006 14th ico 2iosis1979
 
2006 14th ico 1
2006 14th ico 12006 14th ico 1
2006 14th ico 1iosis1979
 
2006 6o παχυσαρκίας
2006 6o παχυσαρκίας2006 6o παχυσαρκίας
2006 6o παχυσαρκίαςiosis1979
 
2005 14th eco3
2005 14th eco32005 14th eco3
2005 14th eco3iosis1979
 
2005 14th eco2
2005 14th eco22005 14th eco2
2005 14th eco2iosis1979
 
2005 14th eco1
2005 14th eco12005 14th eco1
2005 14th eco1iosis1979
 
2004 13th eco
2004 13th eco2004 13th eco
2004 13th ecoiosis1979
 
2003 18th idf
2003 18th idf2003 18th idf
2003 18th idfiosis1979
 
1999 26ο ενδοκρινολογίας2
1999 26ο ενδοκρινολογίας21999 26ο ενδοκρινολογίας2
1999 26ο ενδοκρινολογίας2iosis1979
 
1999 26o eνδοκρινολογίας1
1999 26o eνδοκρινολογίας11999 26o eνδοκρινολογίας1
1999 26o eνδοκρινολογίας1iosis1979
 
1999 3ο παχυσαρκίας3
1999 3ο παχυσαρκίας31999 3ο παχυσαρκίας3
1999 3ο παχυσαρκίας3iosis1979
 
1999 3ο παχυσαρκίας2
1999 3ο παχυσαρκίας21999 3ο παχυσαρκίας2
1999 3ο παχυσαρκίας2iosis1979
 
1999 3ο παχυσαρκίας1
1999 3ο παχυσαρκίας11999 3ο παχυσαρκίας1
1999 3ο παχυσαρκίας1iosis1979
 
1997 bile.8th eco
1997 bile.8th eco1997 bile.8th eco
1997 bile.8th ecoiosis1979
 
1996 23o eνδοκρινολιγικό2
1996 23o eνδοκρινολιγικό21996 23o eνδοκρινολιγικό2
1996 23o eνδοκρινολιγικό2iosis1979
 
1996 23o eνδοκρινολιγικό1
1996 23o eνδοκρινολιγικό11996 23o eνδοκρινολιγικό1
1996 23o eνδοκρινολιγικό1iosis1979
 

More from iosis1979 (20)

Easd 2007
Easd 2007Easd 2007
Easd 2007
 
2009 11ο Διαβητολογικό
2009 11ο Διαβητολογικό2009 11ο Διαβητολογικό
2009 11ο Διαβητολογικό
 
2008 7ο παχυσαρκίας
2008 7ο παχυσαρκίας2008 7ο παχυσαρκίας
2008 7ο παχυσαρκίας
 
2007 15th eco
2007 15th eco2007 15th eco
2007 15th eco
 
2006 14th ico 2
2006 14th ico 22006 14th ico 2
2006 14th ico 2
 
2006 14th ico 1
2006 14th ico 12006 14th ico 1
2006 14th ico 1
 
2006 6o παχυσαρκίας
2006 6o παχυσαρκίας2006 6o παχυσαρκίας
2006 6o παχυσαρκίας
 
2005 14th eco3
2005 14th eco32005 14th eco3
2005 14th eco3
 
2005 14th eco2
2005 14th eco22005 14th eco2
2005 14th eco2
 
2005 14th eco1
2005 14th eco12005 14th eco1
2005 14th eco1
 
2004 13th eco
2004 13th eco2004 13th eco
2004 13th eco
 
2003 18th idf
2003 18th idf2003 18th idf
2003 18th idf
 
1999 26ο ενδοκρινολογίας2
1999 26ο ενδοκρινολογίας21999 26ο ενδοκρινολογίας2
1999 26ο ενδοκρινολογίας2
 
1999 26o eνδοκρινολογίας1
1999 26o eνδοκρινολογίας11999 26o eνδοκρινολογίας1
1999 26o eνδοκρινολογίας1
 
1999 3ο παχυσαρκίας3
1999 3ο παχυσαρκίας31999 3ο παχυσαρκίας3
1999 3ο παχυσαρκίας3
 
1999 3ο παχυσαρκίας2
1999 3ο παχυσαρκίας21999 3ο παχυσαρκίας2
1999 3ο παχυσαρκίας2
 
1999 3ο παχυσαρκίας1
1999 3ο παχυσαρκίας11999 3ο παχυσαρκίας1
1999 3ο παχυσαρκίας1
 
1997 bile.8th eco
1997 bile.8th eco1997 bile.8th eco
1997 bile.8th eco
 
1996 23o eνδοκρινολιγικό2
1996 23o eνδοκρινολιγικό21996 23o eνδοκρινολιγικό2
1996 23o eνδοκρινολιγικό2
 
1996 23o eνδοκρινολιγικό1
1996 23o eνδοκρινολιγικό11996 23o eνδοκρινολιγικό1
1996 23o eνδοκρινολιγικό1
 

1998 8th ico

  • 1. HYPOTHYROIDISM AND BODY WEIGHT: LONG-TERM CHANGES DURING REPLACEMENT THERAPY H. Candiloros E. Georgiadou Authors E. Kapantais A. Mortoglou
  • 2. Department of Endocrinology, Diabetes & Metabolism Athens Medical Centre Hospital, Athens, Greece 8th International congress on Obesity Paris, 29 August - 3 September 1998
  • 3. Introduction  There is a general thought that hypothyroidism is a cause for obesity and that replacement therapy leads to a normalisation of body weight.  The aim is to study body weight in patients with primary hypothyroidism of autoimmune aetiology before and after replacement therapy .
  • 4. Subjects  129 females and 16 males  Age: 50.5±15.1 years (mean±SD)  Initial TSH level >10 mU/ml.
  • 5. Results (Before replacement therapy) • Body Weight= 73.9±14.7 kgr • BMI= 29.3± 5.7 kgr/m2 TSH= 47.6±32.3 mU/ml,T4= 4.06±2.44 μg/dl, T3= 85.8±39.4 ng/dl. 37.9% 31.7% There was no correlation 26.2% between BMI and thyroid hormones.  T4: r= -0.060, p= 0.470  T3: r= 0.019, p= 0.822 4.2%  TSH: r= 0.059, p= 0.477 < 25 25-30 30-40 > 40 BMI 73.8% are overweight or obese
  • 6. Results (6 months after replacement therapy) Dose 125.7±28 μg L-Thyroxine  BW= 71.3±13.1  BMI= 28.5±4.7 T4= 10.3±2.8, T3= 137.7±34.2, TSH= 1.6±2.8 Body Weight decreased by 1.55±4.0 kg (p=0.001) and BMI by 0.626±1.629 (p=0.001)
  • 7. Results (18 months after replacement therapy) Dose 125.4±29 μg L-Thyroxine  BW= 71.2±13.8  BMI= 28.4± 5.4 T4= 10.2±2.3, T3= 128±27.2, TSH= 0.8±1.1 Body Weight decreased by 0.57± 5.1 kgr (p= 0.408) and BMI by 0.262 ± 2.035 (p= 0.344)
  • 8. Multiple regression analysis Body weight changes after 6 months DEP VAR:change of BW N:86 MULTIPLE R:0.636 SQUARED MULTIPLE R:0.405 ADJUSTED SQUARED MULTIPLE R: 0.367 STANDARD ERROR OF ESTIMATE: 3.251 VARIABLE COEFFICIENT STD ERROR STD COEF TOLERANCE T P(2 TAIL) CONSTANT -6.450 2.863 0.000 . -2.253 0.027 Weight 0.070 0.027 0.236 0.890 2.576 0.012 Age 0.084 0.026 0.304 0.874 3.290 0.001 T4-0 -0.633 0.147 -0.377 0.965 -4.294 0.000 T4-6 0.475 0.138 0.326 0.826 3.433 0.001 T3-6 -0.028 0.011 -0.233 0.862 -2.503 0.014 ANALYSIS OF VARIANCE SOURCE SUM-OF-SQUARES DF MEAN-SQUARE F-RATIO P REGRESSION 574.698 5 114.940 10.875 0.000 RESIDUAL 845.552 80 10.569
  • 9. Multiple regression analysis Body weight changes after 18 months DEP VAR:Change BW N:55 MULTIPLE R: 0.650 SQUARED MULTIPLE R:0.422 ADJUSTED SQUARED MULTIPLE R: 0.400 STANDARD ERROR OF ESTIMATE: 3.930 VARIABLE COEFFICIENT STD ERROR STD COEF TOLERANCE T P(2 TAIL) CONSTANT -5.368 2.364 0.000 . -2.270 0.027 Age 0.174 0.040 0.472 0.967 4.403 0.000 T4-0 -0.795 0.230 -0.370 0.967 -3.450 0.001 ANALYSIS OF VARIANCE SOURCE SUM-OF-SQUARES DF MEAN-SQUARE F-RATIO P REGRESSION 587.605 2 293.803 19.021 0.000 RESIDUAL 803.223 52 15.447
  • 10. Conclusions  Patients with primary hypothyroidism are heavier than general population but the degree of hypothyroidism is not related to Body Weight.  The mean weight loss after 6 and 18 months on replacement therapy is negligible (ΔBMI=0.26) and only in elderly patients with profound hypothyroidism and higher initial Body Weight a slight improvement of degree of obesity can be achieved (ΔBMI= 1.81).